2025 annual financial data
Vanda Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was -69.95%.
Operating income was -151,168,000 USD and net income was -220,474,000 USD.
Operating cash flow was -109,442,000 USD.
Get free Vanda Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 216,105,000 USD
- Operating income
- -151,168,000 USD
- Net income
- -220,474,000 USD
- Operating cash flow
- -109,442,000 USD